Back

Pharmacogenetics-guided CETP inhibition: an open question?

European Heart Journal

4 August 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Anne Tybjærg-Hansen
Anne Tybjærg-Hansen

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

Liv Tybjærg Nordestgaard
Liv Tybjærg Nordestgaard

Author

Mette Christoffersen
Mette Christoffersen

Author

You may be interested in
thumbnail
Congress Presentation
Comparing the drug target effects of Cholesteryl ester transfer protein (CETP) on cardiovascular diseases in East Asian and European populations
27 August 2023
thumbnail
Congress Presentation
Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
28 August 2020
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
Obicetrapib and cardiovascular events
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources